08 Jan 2020 Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture Investors | News | Therapeutics
18 Oct 2019 Proposed Placing and Subscription to raise up to £9 million and Notice of General Meeting Investors
29 Jul 2019 Avacta’s Chief Executive Officer to Present at the Solebury Trout European Biotech Investor Day in New York Investors
20 Jun 2019 Avacta and Selexis partner to develop cell line for clinical manufacturing Investors | Therapeutics
12 Jun 2019 Avacta’s Chief Scientific Officer to Present at Major US Conference Investors | Therapeutics